2BB score and signals
Annovis Bio, Inc. Common Stock’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 45 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 20 | Weak |
| Risk | 39 | Low |
Company facts
| CEO | Maria-luisa Maccecchini |
| Headquarters | Malvern, Pennsylvania, United States |
| Founded | 2008 |
| Employees | 8 |
| 52-week range | $1.54 – $5.50 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.4046 | — | $0.00 |
| 2026-08-10 | — | -0.4624 | — | $0.00 |
| 2026-05-15 | -0.63 | -0.4029 | $0.00 | $0.00 |
| 2026-03-13 | -0.39 | -0.3502 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish